Pfizer Inc. raised about £2.55 billion ($3.3 billion) through the sale of its remaining 7.3% stake in Haleon Plc, culminating ...

辉瑞还面临着专利悬崖的压力，核心产品Eliquis在2024年的销售额预计为73.66亿美元，尽管增长势头良好，但Ibrance将在2025年面临专利到期风险。为了应对这一挑战，辉瑞通过ADC药物及新药研发进行核心产品的生命周期管理，积极布局新增长点 ...

Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon ...

Pfizer will sell its remaining stake in British consumer healthcare group Haleon , the companies said on Tuesday.

(Reuters) -Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional ...

美国最大制药商辉瑞公司以25亿英镑（约32.5亿美元）的净价出售了其在伦敦上市的消费者保健公司Haleon剩余的全部7.3%股份。 辉瑞以每股385便士的 ...

其中，原公司副总经理刘爱华女士，已超过法定退休年龄，退休时与公司签订了返聘合同，现该返聘合同将于近期到期，且到期后不再续签。刘爱华女士不再担任副总经理职务，后续将不再在公司担任任何职务。

Pfizer's stock is poised for growth due to its strong pipeline, smart cost management, and recovery from COVID-19 revenue ...

Pfizer has finalized the sale of its entire holding in Haleon , generating approximately 2.5 billion ($3.24 billion), Reuters ...

Pfizer sold its entire 7.3% shareholding in London-listed consumer-health company Haleon for a net sum of 2.5 billion pounds ($3.25 billion). Pfizer sold 618 million shares for 385 pence each. The ...

Bengaluru: Pfizer will divest its remaining stake in Haleon, marking its complete exit from the British consumer healthcare ...

Pfizer Inc. (PFE) agreed to sell its remaining stake worth $3.3 billion in Haleon PLC (HLN), marking its exit from the UK-based consumer ...